ms KRISTEN LAFAYETTE — Lobbyist Profile | Poliscope

ms KRISTEN LAFAYETTE

Filings

Clients

Firms

Years active

2022–2026

Associated filing income

$310,000

How to read the money

Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.

Clients represented

Client	Filings	Years
NATIONAL TBI REGISTRY COALITION	16	2022–2025
VAXXAS INC	15	2022–2025
INTERNATIONAL RETT SYNDROME FOUNDATION	8	2024–2025
THE COALITION FOR THE ADVANCEMENT OF RESEARCH AND INNOVATION IN TRAUMA (CARIT)	7	2022–2023
COHERUS BIOSCIENCES	6	2023–2024
ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE	6	2025–2026

Lobbying firms

Firm	Filings	Years
THE CONAFAY GROUP, LLC	65	2022–2026

Original LDA source filings (65)

Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.

CRESILON, INC. via THE CONAFAY GROUP, LLC

2026 · third_quarter · Q3

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

MAN

Manufacturing

Support for hemostatic technology research and the manufacturing of hemostatic products.

MED

Medical/Disease Research/Clinical Labs

Support for hemostatic technology research and the manufacturing of hemostatic products.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE

Source: Senate LDA

Show 61 more original filings

CRESILON, INC. via THE CONAFAY GROUP, LLC

2026 · second_quarter · RR

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

MED

Medical/Disease Research/Clinical Labs

Support for hemostatic technology research and the manufacturing of hemostatic products.

MAN

Manufacturing

Support for hemostatic technology research and the manufacturing of hemostatic products.

ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE via THE CONAFAY GROUP, LLC

2026 · first_quarter · Q1

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

BUD

Budget/Appropriations

Support for biomedical research.

DEF

Defense

Support for biomedical research.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE via THE CONAFAY GROUP, LLC

2025 · third_quarter · Q3

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Support for biomedical research.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

INTERNATIONAL RETT SYNDROME FOUNDATION via THE CONAFAY GROUP, LLC

2025 · third_quarter · 3T

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

MED

Medical/Disease Research/Clinical Labs

Support for biomedical research.

BUD

Budget/Appropriations

Support for biomedical research.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

VAXXAS INC via THE CONAFAY GROUP, LLC

2025 · third_quarter · Q3

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Support for vaccination technology.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE via THE CONAFAY GROUP, LLC

2025 · second_quarter · Q2

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Support for biomedical research.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

VAXXAS INC via THE CONAFAY GROUP, LLC

2025 · second_quarter · Q2

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Support for vaccination technology.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

INTERNATIONAL RETT SYNDROME FOUNDATION via THE CONAFAY GROUP, LLC

2025 · second_quarter · Q2

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

BUD

Budget/Appropriations

Support for biomedical research.

MED

Medical/Disease Research/Clinical Labs

Support for biomedical research.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

VAXXAS INC via THE CONAFAY GROUP, LLC

2025 · first_quarter · Q1

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Support for vaccination technology.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE via THE CONAFAY GROUP, LLC

2025 · first_quarter · Q1

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Support for biomedical research.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

NATIONAL TBI REGISTRY COALITION via THE CONAFAY GROUP, LLC

2025 · first_quarter · Q1

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Support for a national TBI registry.

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

INTERNATIONAL RETT SYNDROME FOUNDATION via THE CONAFAY GROUP, LLC

2025 · first_quarter · Q1

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

MED

Medical/Disease Research/Clinical Labs

Support for biomedical research.

BUD

Budget/Appropriations

Support for biomedical research.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE via THE CONAFAY GROUP, LLC

2024 · fourth_quarter · Q4

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Support for biomedical research.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

VAXXAS INC via THE CONAFAY GROUP, LLC

2024 · fourth_quarter · Q4

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Support for vaccination technology.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

NATIONAL TBI REGISTRY COALITION via THE CONAFAY GROUP, LLC

2024 · fourth_quarter · Q4

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Support for a national TBI registry.

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

INTERNATIONAL RETT SYNDROME FOUNDATION via THE CONAFAY GROUP, LLC

2024 · fourth_quarter · Q4

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

BUD

Budget/Appropriations

Support for biomedical research.

MED

Medical/Disease Research/Clinical Labs

Support for biomedical research.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

NATIONAL TBI REGISTRY COALITION via THE CONAFAY GROUP, LLC

2024 · third_quarter · Q3

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Support for a national TBI registry.

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

VAXXAS INC via THE CONAFAY GROUP, LLC

2024 · third_quarter · Q3

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Support for vaccination technology.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

INTERNATIONAL RETT SYNDROME FOUNDATION via THE CONAFAY GROUP, LLC

2024 · third_quarter · Q3

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

BUD

Budget/Appropriations

Support for biomedical research.

MED

Medical/Disease Research/Clinical Labs

Support for biomedical research.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE via THE CONAFAY GROUP, LLC

2024 · third_quarter · Q3

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Support for biomedical research.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

COHERUS BIOSCIENCES via THE CONAFAY GROUP, LLC

2024 · second_quarter · 2T

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

MED

Medical/Disease Research/Clinical Labs

Lobbying for procurement of American made biosimilars.

HCR

Health Issues

Lobbying for procurement of American made biosimilars.

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

NATIONAL TBI REGISTRY COALITION via THE CONAFAY GROUP, LLC

2024 · second_quarter · Q2

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Support for a national TBI registry.

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

VAXXAS INC via THE CONAFAY GROUP, LLC

2024 · second_quarter · Q2

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Support for vaccination technology.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE via THE CONAFAY GROUP, LLC

2024 · second_quarter · Q2

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Support for biomedical research.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

INTERNATIONAL RETT SYNDROME FOUNDATION via THE CONAFAY GROUP, LLC

2024 · second_quarter · Q2

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

BUD

Budget/Appropriations

Support for biomedical research.

MED

Medical/Disease Research/Clinical Labs

Support for biomedical research.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE via THE CONAFAY GROUP, LLC

2024 · second_quarter · RR

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Increased funding for medical research.

COHERUS BIOSCIENCES via THE CONAFAY GROUP, LLC

2024 · first_quarter · Q1

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

Lobbying for procurement of American made biosimilars.

MED

Medical/Disease Research/Clinical Labs

Lobbying for procurement of American made biosimilars.

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

INTERNATIONAL RETT SYNDROME FOUNDATION via THE CONAFAY GROUP, LLC

2024 · first_quarter · Q1

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

BUD

Budget/Appropriations

Support research for Rett syndrome and rare diseases.

MED

Medical/Disease Research/Clinical Labs

Support research for Rett syndrome and rare diseases.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

VAXXAS INC via THE CONAFAY GROUP, LLC

2024 · first_quarter · Q1

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Support for vaccination technology.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

NATIONAL TBI REGISTRY COALITION via THE CONAFAY GROUP, LLC

2024 · first_quarter · Q1

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Support for a national TBI registry.

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

INTERNATIONAL RETT SYNDROME FOUNDATION via THE CONAFAY GROUP, LLC

2024 · first_quarter · RR

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

BUD

Budget/Appropriations

Advocacy and education about Rett Syndrome. Seek funding for research for Rett Syndrome.

MED

Medical/Disease Research/Clinical Labs

Advocacy and education about Rett Syndrome. Seek funding for research for Rett Syndrome.

COHERUS BIOSCIENCES via THE CONAFAY GROUP, LLC

2023 · fourth_quarter · Q4

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

Lobbying for procurement of American made biosimilars.

MED

Medical/Disease Research/Clinical Labs

Lobbying for procurement of American made biosimilars.

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

VAXXAS INC via THE CONAFAY GROUP, LLC

2023 · fourth_quarter · Q4

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Support for vaccination technology.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

NATIONAL TBI REGISTRY COALITION via THE CONAFAY GROUP, LLC

2023 · fourth_quarter · Q4

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Support for a national TBI registry.

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

COHERUS BIOSCIENCES via THE CONAFAY GROUP, LLC

2023 · third_quarter · Q3

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

Lobbying for procurement of American made biosimilars.

MED

Medical/Disease Research/Clinical Labs

Lobbying for procurement of American made biosimilars.

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

THE COALITION FOR THE ADVANCEMENT OF RESEARCH AND INNOVATION IN TRAUMA (CARIT) via THE CONAFAY GROUP, LLC

2023 · third_quarter · Q3

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

BUD

Budget/Appropriations

Support for trauma research.

MED

Medical/Disease Research/Clinical Labs

Support for trauma research.

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE

NATIONAL TBI REGISTRY COALITION via THE CONAFAY GROUP, LLC

2023 · third_quarter · Q3

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Support for a national TBI registry.

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

VAXXAS INC via THE CONAFAY GROUP, LLC

2023 · third_quarter · Q3

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Support for vaccination technology.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

COHERUS BIOSCIENCES via THE CONAFAY GROUP, LLC

2023 · second_quarter · Q2

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

Lobbying for procurement of American made biosimilars.

MED

Medical/Disease Research/Clinical Labs

Lobbying for procurement of American made biosimilars.

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

NATIONAL TBI REGISTRY COALITION via THE CONAFAY GROUP, LLC

2023 · second_quarter · Q2

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Support for a national TBI registry.

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

VAXXAS INC via THE CONAFAY GROUP, LLC

2023 · second_quarter · Q2

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Research on vaccine technology.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

THE COALITION FOR THE ADVANCEMENT OF RESEARCH AND INNOVATION IN TRAUMA (CARIT) via THE CONAFAY GROUP, LLC

2023 · second_quarter · Q2

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

MED

Medical/Disease Research/Clinical Labs

Support for trauma research.

BUD

Budget/Appropriations

Support for trauma research.

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE

COHERUS BIOSCIENCES via THE CONAFAY GROUP, LLC

2023 · second_quarter · RR

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

MED

Medical/Disease Research/Clinical Labs

Lobbying for procurement of American made biosimilars.

HCR

Health Issues

Lobbying for procurement of American made biosimilars.

NATIONAL TBI REGISTRY COALITION via THE CONAFAY GROUP, LLC

2023 · first_quarter · Q1

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Support for a national TBI registry.

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

NATIONAL TBI REGISTRY COALITION via THE CONAFAY GROUP, LLC

2023 · first_quarter · Q1

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Support for a national TBI registry.

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

VAXXAS INC via THE CONAFAY GROUP, LLC

2023 · first_quarter · Q1

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Research on vaccine technology.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

THE COALITION FOR THE ADVANCEMENT OF RESEARCH AND INNOVATION IN TRAUMA (CARIT) via THE CONAFAY GROUP, LLC

2023 · first_quarter · Q1

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

MED

Medical/Disease Research/Clinical Labs

Support for trauma research.

BUD

Budget/Appropriations

Support for trauma research.

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE

NATIONAL TBI REGISTRY COALITION via THE CONAFAY GROUP, LLC

2022 · first_quarter · RA

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Advocate for national registry for individuals with traumatic brain injury.

VAXXAS INC via THE CONAFAY GROUP, LLC

2022 · fourth_quarter · Q4

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Support for vaccine research.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

NATIONAL TBI REGISTRY COALITION via THE CONAFAY GROUP, LLC

2022 · fourth_quarter · Q4

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Advocate for national registry for individuals with traumatic brain injuries.

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

THE COALITION FOR THE ADVANCEMENT OF RESEARCH AND INNOVATION IN TRAUMA (CARIT) via THE CONAFAY GROUP, LLC

2022 · fourth_quarter · Q4

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

MED

Medical/Disease Research/Clinical Labs

Support for trauma research.

BUD

Budget/Appropriations

Support for trauma research.

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE

VAXXAS INC via THE CONAFAY GROUP, LLC

2022 · third_quarter · Q3

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Support for vaccine research

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

NATIONAL TBI REGISTRY COALITION via THE CONAFAY GROUP, LLC

2022 · third_quarter · Q3

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Advocate for national registry for individuals with traumatic brain injuries.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

THE COALITION FOR THE ADVANCEMENT OF RESEARCH AND INNOVATION IN TRAUMA (CARIT) via THE CONAFAY GROUP, LLC

2022 · third_quarter · Q3

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

MED

Medical/Disease Research/Clinical Labs

Support for trauma research

BUD

Budget/Appropriations

Support for trauma research

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE

VAXXAS INC via THE CONAFAY GROUP, LLC

2022 · second_quarter · Q2

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Support for vaccine research

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

NATIONAL TBI REGISTRY COALITION via THE CONAFAY GROUP, LLC

2022 · second_quarter · Q2

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Advocate for national registry for individuals with traumatic brain injuries.

Filing targets: HOUSE OF REPRESENTATIVES

THE COALITION FOR THE ADVANCEMENT OF RESEARCH AND INNOVATION IN TRAUMA (CARIT) via THE CONAFAY GROUP, LLC

2022 · second_quarter · Q2

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

MED

Medical/Disease Research/Clinical Labs

Support for trauma research

BUD

Budget/Appropriations

Support for trauma research

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE

VAXXAS INC via THE CONAFAY GROUP, LLC

2022 · second_quarter · RR

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Support for medical research

NATIONAL TBI REGISTRY COALITION via THE CONAFAY GROUP, LLC

2022 · first_quarter · Q1

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Advocate for national registry for individuals with traumatic brain injuries.

Filing targets: HOUSE OF REPRESENTATIVES

NATIONAL TBI REGISTRY COALITION via THE CONAFAY GROUP, LLC

2022 · first_quarter · RR

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Advocate for national registry for individuals with traumatic brain injury.

THE COALITION FOR THE ADVANCEMENT OF RESEARCH AND INNOVATION IN TRAUMA (CARIT) via THE CONAFAY GROUP, LLC

2022 · first_quarter · Q1

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

BUD

Budget/Appropriations

Support for trauma research

MED

Medical/Disease Research/Clinical Labs

Support for trauma research

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE